Company page

Oric Pharmaceuticals, Inc.

Oric Pharmaceuticals, Inc. is a public company traded under the ticker ORIC in the American market. With a market capitalization of approximately $878.9 million, the company focuses on developing innovative therapies for cancer treatment. Oric is committed to advancing its pipeline to address unmet medical needs in oncology.